These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Constitutive protease-activated receptor-2-mediated migration of MDA MB-231 breast cancer cells requires both beta-arrestin-1 and -2. Ge L, Shenoy SK, Lefkowitz RJ, DeFea K. J Biol Chem; 2004 Dec 31; 279(53):55419-24. PubMed ID: 15489220 [Abstract] [Full Text] [Related]
3. Protease-activated receptor-2 simultaneously directs beta-arrestin-1-dependent inhibition and Galphaq-dependent activation of phosphatidylinositol 3-kinase. Wang P, DeFea KA. Biochemistry; 2006 Aug 08; 45(31):9374-85. PubMed ID: 16878972 [Abstract] [Full Text] [Related]
5. Divergent β-arrestin-dependent signaling events are dependent upon sequences within G-protein-coupled receptor C termini. Pal K, Mathur M, Kumar P, DeFea K. J Biol Chem; 2013 Feb 01; 288(5):3265-74. PubMed ID: 23235155 [Abstract] [Full Text] [Related]
15. The role of palmitoylation in signalling, cellular trafficking and plasma membrane localization of protease-activated receptor-2. Adams MN, Christensen ME, He Y, Waterhouse NJ, Hooper JD. PLoS One; 2011 Jul 13; 6(11):e28018. PubMed ID: 22140500 [Abstract] [Full Text] [Related]
17. Activation of MAPK by TRH requires clathrin-dependent endocytosis and PKC but not receptor interaction with beta-arrestin or receptor endocytosis. Smith J, Yu R, Hinkle PM. Mol Endocrinol; 2001 Sep 13; 15(9):1539-48. PubMed ID: 11518803 [Abstract] [Full Text] [Related]
19. β-Arrestin-2 mediates the proinflammatory effects of proteinase-activated receptor-2 in the airway. Nichols HL, Saffeddine M, Theriot BS, Hegde A, Polley D, El-Mays T, Vliagoftis H, Hollenberg MD, Wilson EH, Walker JK, DeFea KA. Proc Natl Acad Sci U S A; 2012 Oct 09; 109(41):16660-5. PubMed ID: 23012429 [Abstract] [Full Text] [Related]